Managing Director Glenn Smith provides an overview of TALi Digital's (ASX: TD1) world first personalised digital test and treatment platform for early childhood attention. During the session, Glenn discusses the company's global market presence, unique market advantage, and commercial roll out across Australia, India, the US and UK.

TALi Digital (ASX: TD1) is an Australian Medical Technology Company seeking to improve attention in early childhood through its breakthrough TALi platform.

Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.

Accurate time of recording, 21 October 2020 at 12pm AEDT.